4.2 Editorial Material

Part I: Checkpoint inhibitors in cancer therapy

Journal

IMMUNOTHERAPY
Volume 8, Issue 6, Pages 675-676

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/imt-2016-0051

Keywords

adverse events; checkpoints; epigenetic modulation; MDSC; mismatch repair; T-regs

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available